Urbana

Eureka Therapeutics Inc, located in Emeryville, CA, is a biotechnology company specializing in innovative therapies for cancer treatment. Their cutting-edge technologies, including the E-ALPHA Phage Display Platform and ARTEMIS Cell Receptor Platform, have gained recognition in the scientific community and have been published in numerous scientific publications. With a strong focus on T-cell therapy, Eureka Therapeutics aims to revolutionize cancer treatment by developing personalized therapies that harness the power of the patient's own immune system. Led by their experienced Chief Financial Officer, Alexa Willson, the company benefits from her extensive background in corporate finance and strategy, as well as her expertise in capital raising and mergers and acquisitions.Generated from the website

The Asian Pacific Islander American Health Forum (APIAHF) is a leading organization dedicated to advocating for the health and well-being of Asian Americans and Native Hawaiians, as well as Pacific Islanders in the United States. With over 35 years of experience, APIAHF works tirelessly to address health care access, quality, and equity issues faced by these communities. Through policy analysis, capacity building, and engagement initiatives, APIAHF collaborates with community organizations and policymakers to ensure that nearly 25 million individuals have access to affordable and culturally appropriate health care. APIAHF's impactful work includes enrolling close to 1 million Asian Americans and Native Hawaiians and Pacific Islanders in the Affordable Care Act, as well as partnering with over 150 community organizations across all states and U.S. territories. Their focus on health equity and accountability is evident through their efforts to reduce barriers and improve access to quality health care for these underserved populations. APIAHF's dedication to advancing racial equity and promoting the well-being of Asian American and Pacific Islander communities makes them a vital voice in the fight for health equity in the United States.Generated from the website

The Smith-Kettlewell Eye Research Institute (SKERI) is a nonprofit independent research institute located in San Francisco, dedicated to advancing research in vision science since 1960. Its mission is to enhance the understanding of normal vision and develop diagnostic procedures and treatments for visual disorders, while also focusing on rehabilitation techniques for the blind and partially sighted. SKERI is actively involved in various research projects, with a particular emphasis on low vision rehabilitation and the development of assistive technologies. The institute encourages community participation through internships and volunteer opportunities, fostering a collaborative environment aimed at making a significant impact in the field of vision science. Generated from the website